The Choice of Jet Nebulizer, Nebulizing Flow, and Addition of Albuterol Affects the Output of Tobramycin Aerosols
- 1 May 1997
- Vol. 111 (5) , 1206-1212
- https://doi.org/10.1378/chest.111.5.1206
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Nebulizer delivery of tobramycin to the lower respiratory tractPediatric Pulmonology, 1994
- Efficacy of Aerosolized Tobramycin in Patients with Cystic FibrosisNew England Journal of Medicine, 1993
- Jet and ultrasonic nebuliser output: use of a new method for direct measurement of aerosol output.Thorax, 1990
- Long‐term effects of inhaled tobramycin in patients with cystic fibrosis colonized with Pseudomonas aeruginosaPediatric Pulmonology, 1989
- Long‐term tobramycin aerosol therapy in cystic fibrosisPediatric Pulmonology, 1989
- Safety of aerosol tobramycin administration for 3 months to patients with cystic fibrosisPediatric Pulmonology, 1989
- Inhaled ceftazidime compared with gentamicin and carbenicillin in older patients with cystic fibrosis infected with Pseudomonas aeruginosaRespiratory Medicine, 1987
- Efficacy of inhaled amikacin as adjunct to intravenous combination therapy (ceftazidime and amikacin) in cystic fibrosisThe Journal of Pediatrics, 1987
- INHALED ANTIBIOTICS IN CYSTIC FIBROSISThe Lancet, 1983
- AEROSOL CARBENICILLIN AND GENTAMICIN TREATMENT OF PSEUDOMONAS AERUGINOSA INFECTION IN PATIENTS WITH CYSTIC FIBROSISThe Lancet, 1981